By approving the loan, the shareholders' meeting authorised the Board of Directors to also issue rights convertible into Actavis Group shares.
REYKJAVIK, July 26 (Hina) - The shareholders' meeting of the Icelandic pharmaceutical company Actavis has authorised the Board of Directors to take out a EUR525 million loan and issue 300 million new Class A shares to fund the
acquisition of the Croatian pharmaceutical company Pliva, according to resolutions of the shareholders' meeting issued on Wednesday.
REYKJAVIK, July 26 (Hina) - The shareholders' meeting of the
Icelandic pharmaceutical company Actavis has authorised the Board of Directors
to take out a EUR525 million loan and issue 300 million new Class A shares to
fund the acquisition of the Croatian pharmaceutical company Pliva, according to
resolutions of the shareholders' meeting issued on Wednesday.
(Hina) ha